|
||||||||||||||||||
|
||||||||||||||||||
Press Release October 27, 2004 Contact: Joycelyn Woods (212) 595-6262 A Methadone Treatment Center in Alabama, “Shelby County Treatment Center” is under fire. After four trials, with no testimony or witnesses against them, a local county Judge granted a permanent injunction and says they have to stay closed. The State of Alabama that grants permission…
Batki, S.L. Treatment of intravenous drug users with AIDS: The role of methadone maintenance. Journal of Psychoactive Drugs 1988 20: 213-216. Legal Action Center. Beazer vs New York City Transit Authority: A Landmark Decision on Methadone Maintenance [Report]. New York: National Institute on Drug Abuse, 1975. Des Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et…
Education Series Number 5.1 February 2001 (Revised) Joycelyn Woods has a graduate degree in neuroscience and psychopharmacology. She has published in neuroscience journals and is recognized internationally for her methadone advocacy work. She is a recipient of the “Richard Lane Methadone Advocacy Award.” The Lack of Education Ignorance about methadone abounds (Zweben and Sorensen, 1988)….
Substance Abuse Mental Health Services Administration FAQ July 22, 1999 1. Why is the Department of Health and Human Services (HHS) moving away from direct federal inspection by the FDA to surveys by accreditation organizations? HHS is proposing to move to an accreditation system to improve the quality of treatment for patients. While FDA regulation…
Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…
Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…